Private Advisor Group’s Surface Oncology, Inc. Common Stock SURF Stock Holding History

Private Advisor Group’s Portfolio SURF Stock Details SURF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-17,325	Closed	-$15.1K	–	2390
2023 Q2	$15.1K	Hold	17,325	–	–	﹤0.01%	1997
2023 Q1	$12.1K	Hold	17,325	–	–	﹤0.01%	1942
2022 Q4	$14	Hold	17,325	–	–	﹤0.01%	1651
2022 Q3	$18K	Hold	17,325	–	–	﹤0.01%	1880
2022 Q2	$28K	Hold	17,325	–	–	﹤0.01%	2056
2022 Q1	$51K	Buy	17,325 +80	+0.5%	+$280	﹤0.01%	2040
2021 Q4	$82K	Hold	17,245	–	–	﹤0.01%	2044
2021 Q3	$131K	Buy	17,245 +110	+0.6%	+$704	﹤0.01%	1929
2021 Q2	$128K	Hold	17,135	–	–	﹤0.01%	1887
2021 Q1	$134K	Buy	17,135 +1,135	+7%	+$11.3K	﹤0.01%	1785
2020 Q4	$148K	Sell	16,000 -2,000	-11%	-$17.4K	﹤0.01%	1668
2020 Q3	$124K	Buy	+18,000	New	+$109K	﹤0.01%	1468

Private Advisor Group's SURF Position: Q3 2023 in Review

Private Advisor Group sold out of Surface Oncology, Inc. Common Stock (SURF) in Q3 2023, closing a stake of 17,325 shares — an estimated $15.1K sold.

Private Advisor Group first reported a position in SURF in Q3 2020 and held it in 12 quarters. The position peaked at $148K in Q4 2020. 0 funds tracked by Wall St. Rank hold SURF as of Q3 2023.

Private Advisor Group reported no remaining Surface Oncology, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Private Advisor Group sold 17,325 Surface Oncology, Inc. Common Stock shares in Q3 2023, an estimated $15.1K.
Private Advisor Group first reported a position in Surface Oncology, Inc. Common Stock in Q3 2020 and held it in 12 quarters.
Private Advisor Group's Surface Oncology, Inc. Common Stock position peaked at $148K in Q4 2020.
0 funds tracked by Wall St. Rank held Surface Oncology, Inc. Common Stock as of Q3 2023.

Based on Private Advisor Group's 13F filing for Q3 2023, filed 3 Nov 2023.